Literature DB >> 15448393

Management of pelvic inflammatory disease in adolescents.

Dilip R Patel1.   

Abstract

Pelvic inflammatory disease (PID) is highly prevalent among sexually active adolescent females. The major organisms are N gonorrhoeae and C trachomatis. Diagnosis is based on historical information and clinical findings. Early diagnosis and treatment effectively reduce the incidence of complications associated with PID. Highly effective treatment regimens are available and main antimicrobials used include quinolones, cephalosporins, metronidazole, doxycycline, and azithromycin. Delay or inadequate treatment is associated with long term sequelae including tubal infertility and chronic pelvic pain. Prevention efforts should be directed towards routine screening and treatment for sexually transmissible infections, public education and provision of resources for treatment and follow-up.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15448393     DOI: 10.1007/bf02730726

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  8 in total

Review 1.  Pelvic inflammatory disease: new diagnostic criteria and treatment.

Authors:  Richard H Beigi; Harold C Wiesenfeld
Journal:  Obstet Gynecol Clin North Am       Date:  2003-12       Impact factor: 2.844

Review 2.  Clinical practice. Genital chlamydial infections.

Authors:  Jeffrey F Peipert
Journal:  N Engl J Med       Date:  2003-12-18       Impact factor: 91.245

Review 3.  Sexually transmissible infections other than HIV.

Authors:  Basil Donovan
Journal:  Lancet       Date:  2004-02-14       Impact factor: 79.321

Review 4.  Sexually transmitted disease screening in teens.

Authors:  Jill S Huppert; Paula J Adams Hillard
Journal:  Curr Womens Health Rep       Date:  2003-12

5.  A randomized controlled trial of azithromycin versus doxycycline/ciprofloxacin for the syndromic management of sexually transmitted infections in a resource-poor setting.

Authors:  Roxana Rustomjee; A B M Kharsany; C A Connolly; S S Abdool Karim
Journal:  J Antimicrob Chemother       Date:  2002-05       Impact factor: 5.790

6.  Identification of symptoms that indicate a pelvic examination is necessary to exclude PID in adolescent women.

Authors:  D R Blake; K Fletcher; N Joshi; S J Emans
Journal:  J Pediatr Adolesc Gynecol       Date:  2003-02       Impact factor: 1.814

Review 7.  Pelvic inflammatory disease: how should it be managed?

Authors:  Jonathan D C Ross
Journal:  Curr Opin Infect Dis       Date:  2003-02       Impact factor: 4.915

8.  Efficacy and safety of azithromycin as monotherapy or combined with metronidazole compared with two standard multidrug regimens for the treatment of acute pelvic inflammatory disease.

Authors:  C D Bevan; G L Ridgway; C D Rothermel
Journal:  J Int Med Res       Date:  2003 Jan-Feb       Impact factor: 1.671

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.